161 related articles for article (PubMed ID: 34970856)
1. The effect of colchicine on mortality outcome and duration of hospital stay in patients with COVID-19: A meta-analysis of randomized trials.
Kow CS; Lee LH; Ramachandram DS; Hasan SS; Ming LC; Goh HP
Immun Inflamm Dis; 2022 Feb; 10(2):255-264. PubMed ID: 34970856
[TBL] [Abstract][Full Text] [Related]
2. Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation.
Bonaventura A; Vecchié A; Dagna L; Tangianu F; Abbate A; Dentali F
Inflamm Res; 2022 Mar; 71(3):293-307. PubMed ID: 35113170
[TBL] [Abstract][Full Text] [Related]
3. Colchicine use might be associated with lower mortality in COVID-19 patients: A meta-analysis.
Elshafei MN; El-Bardissy A; Khalil A; Danjuma M; Mubasher M; Abubeker IY; Mohamed MFH
Eur J Clin Invest; 2021 Sep; 51(9):e13645. PubMed ID: 34185313
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of colchicine in COVID-19 patients: A systematic review and meta-analysis of randomized control trials.
Yasmin F; Najeeb H; Moeed A; Hassan W; Khatri M; Asghar MS; Naveed AK; Ullah W; Surani S
PLoS One; 2022; 17(4):e0266245. PubMed ID: 35381033
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of colchicine in patients with moderate COVID-19: A double-blinded, randomized, placebo-controlled trial.
Rahman M; Datta PK; Islam K; Haque M; Mahmud R; Mallik U; Hasan P; Haque M; Faruq I; Sharif M; Ratul RH; Azad KAK; Miah T; Rahman MM
PLoS One; 2022; 17(11):e0277790. PubMed ID: 36383611
[TBL] [Abstract][Full Text] [Related]
6. Can we still consider treatment with colchicine effective in SARS-COV-2 infection? Systematic review, meta-analysis, and trial sequential analysis.
De-Miguel-Balsa E; Estevan-Ortega R; Sempere-Selva MT; Latour-Pérez J; Baeza-Román A; Moya-Martinez A; Ramos-Rincon JM
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7151-7161. PubMed ID: 34859881
[TBL] [Abstract][Full Text] [Related]
7. Colchicine treatment can improve outcomes of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
Hariyanto TI; Halim DA; Jodhinata C; Yanto TA; Kurniawan A
Clin Exp Pharmacol Physiol; 2021 Jun; 48(6):823-830. PubMed ID: 33719081
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
9. Effect of colchicine on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomised controlled trials.
Lan SH; Hsu CK; Lai CC; Chang SP; Lu LC; Hung SH; Lin WT
Ann Med; 2022 Dec; 54(1):1956-1965. PubMed ID: 35833737
[TBL] [Abstract][Full Text] [Related]
10. Colchicine and mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression.
Nawangsih EN; Kusmala YY; Rakhmat II; Handayani DR; Juliastuti H; Wibowo A; Lim MA; Pranata R
Int Immunopharmacol; 2021 Jul; 96():107723. PubMed ID: 34162130
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of colchicine in the management of coronavirus disease 2019: A protocol for systematic review and meta-analysis.
Elshafei MN; Khalil A; El-Bardissy A; Danjuma M; Ahmed MB; Mohamed MFH
Medicine (Baltimore); 2020 Sep; 99(36):e21911. PubMed ID: 32899023
[TBL] [Abstract][Full Text] [Related]
13. Effect of colchicine on mortality in patients with COVID-19 - A systematic review and meta-analysis.
Zein AFMZ; Raffaello WM
Diabetes Metab Syndr; 2022 Feb; 16(2):102395. PubMed ID: 35078098
[TBL] [Abstract][Full Text] [Related]
14. Oxygen Saturation in Hospitalized COVID-19 Patients and Its Relation to Colchicine Treatment: A Retrospective Cohort Study with an Updated Systematic Review.
Sharaf S; Ashmawy R; Saleh E; Salama M; El-Maradny YA; Zari A; Aly S; Tolba A; Mahrous D; Elsayed H; Latif D; Redwan EM; Kamal E
Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241167
[No Abstract] [Full Text] [Related]
15. Convalescent Plasma for Patients Hospitalized With Coronavirus Disease 2019: A Meta-Analysis With Trial Sequential Analysis of Randomized Controlled Trials.
Ling RR; Sim JJL; Tan FL; Tai BC; Syn N; Mucheli SS; Fan BE; Mitra S; Ramanathan K
Transfus Med Rev; 2022 Jan; 36(1):16-26. PubMed ID: 34782209
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of early colchicine administration in patients over 60 years old with high risk of developing severe pulmonary complications associated with coronavirus pneumonia SARS-CoV-2 (COVID-19): study protocol for an investigator-driven randomized controlled clinical trial in primary health care-COLCHICOVID study.
Estebanez EB; Alconero LL; Fernández BJ; Marguello MG; Caro JCL; Vallejo JD; Sampedro MF; Cacho PM; Espiga CR; Saiz MMG
Trials; 2021 Sep; 22(1):590. PubMed ID: 34488841
[TBL] [Abstract][Full Text] [Related]
17. Adding Colchicine to the Antiretroviral Medication - Lopinavir/Ritonavir (Kaletra) in Hospitalized Patients with Non-Severe Covid-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomized Controlled Trial.
Dalili N; Kashefizadeh A; Nafar M; Poorrezagholi F; Firouzan A; Samadian F; Samavat S; Ziaie S; Fatemizadeh S
Trials; 2020 Jun; 21(1):489. PubMed ID: 32503620
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of colchicine in COVID-19: a meta-analysis of randomised controlled trials.
Mehta KG; Patel T; Chavda PD; Patel P
RMD Open; 2021 Oct; 7(3):. PubMed ID: 34810227
[TBL] [Abstract][Full Text] [Related]
19. The effect of higher-intensity dosing of anticoagulation on the clinical outcomes in hospitalized patients with COVID-19: A meta-analysis of randomized controlled trials.
Kow CS; Ramachandram DS; Hasan SS
J Infect Chemother; 2022 Feb; 28(2):257-265. PubMed ID: 34840039
[TBL] [Abstract][Full Text] [Related]
20. Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients.
Amaral NB; Rodrigues TS; Giannini MC; Lopes MI; Bonjorno LP; Menezes PISO; Dib SM; Gigante SLG; Benatti MN; Rezek UC; Emrich-Filho LL; Sousa BA; Almeida SCL; Luppino-Assad R; Veras FP; Schneider AH; Leiria LOS; Cunha LD; Alves-Filho JC; Cunha TM; Arruda E; Miranda CH; Pazin-Filho A; Auxiliadora-Martins M; Borges MC; Fonseca BAL; Bollela VR; Del-Ben CM; Cunha FQ; Santana RC; Vilar FC; Zamboni DS; Louzada-Junior P; Oliveira RDR
Inflamm Res; 2023 May; 72(5):895-899. PubMed ID: 36917217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
